Life Line Screening Enjoy Better Health With Regular Health Screenings

People need to make sure that they visit their doctor periodically and get their health checkups at least twice a year, even if they feel everything is fine with their health. Such health checkups are necessary these days because at times, the diseases and health conditions continue to develop inside the body without any symptoms for it surfacing. It makes it difficult for the people to identify any problems with their health and by the time the disease is discovered, it has grown manifolds. Going for regular health screenings makes it easier to know the status of the health and take any corrective measures at the right time before it’s too late.

Life Line Screening is one of the most familiar names when it comes to health screenings in the United States. It is a community-based health screening services that have its headquarters in Independence, Cleveland. The organization was established in the year 1993 and has grown exponentially since then. Life Line Screenings offer a wide range of screenings for different health conditions and ensure that the clients get the accurate results, always. The lifestyle of the people has changed over the years, and unfortunately, it is slightly inclined towards the unhealthy side. It is causing people to start having health concerns from a very young age.

However, any health concerns can be addressed at a very early stage if it is identified in time. The medical science has advanced these days drastically and there are health screenings available that can detect different diseases with simple non-invasive or minimally invasive health screenings. Such health screenings have become highly relevant these days, and most physicians recommend comprehensive health check-up twice a year or at least once a year. If you are going for health screening at Life Line Screening, make sure that you have not eaten too slowly and had a simple light meal. Also, it is essential that you do not wear too many clothes or layers of clothes as chances are that for some of the tests, you might have to change to the clinical gown.

The staffs at Life Line Screening are very friendly and professional, and they would guide you through the test and ensure that you have a smooth, painless experience. Make sure that you stay calm and calm during the test for the best results. Do not put on any kind of makeup or lotion on your body before the test and do know that phones are not allowed during the period test is being conducted.




Amicus Therapeutics, successful ventures in biopharmaceutical

Amicus Therapeutics is an American public biopharmaceutical firm situated in Cranbury, New Jersey. In the year 2007, the company penetrated so much into the public domain under the NASDAQ trading symbol FOLD.


While in 2006, there followed a planned offering as well as a subsequent withdrawal that would have instituted the trading symbol as AMTX. Before their IPO, the Amicus was funded by various venture capital companies such as Canaan Partners and New Enterprise Associates.


The therapeutic focal point of Amicus is on rare and orphan ailments such as the disorders referred to as lysosomal storage disorders. Amicus Therapeutics develop products that are mainly based on the Chaperone-Advanced Replacement Therapy platform as well as focused on developing of enzyme replacement therapies.


During February 2014, the firm had not market any products. It’s most superior candidate was the migalastat which was a pharmacological chaperone treatment meant for Fabry disease that aimed at stabilizing endogenous mutant alpha-galactosidase.


Amicus Therapeutics company also engaged in a group effort with GlaxoSmithKline as well as JCR Pharmaceutical in parallel with the advancement of migalastat monotherapy. The collaboration was meant to examine co-formulation with recombinant alpha-galactoside. The partnership which started in 2010, lasted for three years.


As a matter of fact, Amicus Therapeutics does not possess a manufacturing ability but rather depend on contract manufacturing only. Amicus Therapeutics expanded from a single site in New Jersey during 2008 to a second research location in San Diego (Glassdoor).


Amicus Therapeutics faced a myriad of the financial crisis in 2009 following the early termination of a long-term collaboration agreement with The Shire. During the completion, operation financing was carried through the private placement of redeemable convertible preferred stock, returns from initial public offering as well as from previous partnership agreement with The Shire. As a result, the Amicus Therapeutics embarked on a restructuring process that was meant to optimize returns while minimizing costs.


Amicus bumped into Callidus Biopharma in November 2013 as a competitor and acquired exclusive materials as well as intellectual property for enzyme replacement therapy cure of Pompe ailment.


The Chief Executive officer of Amicus Therapeutics since 2005, has been John F. Crowly. The latter succeeded Donald Hayden as the firm’s board chairman (YahooFinance).

 or check them out on Facebook